Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin a injection alone: a split‐face, rater‐blinded, randomized control trial
- 4 December 2013
- journal article
- research article
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 12 (4) , 261-266
Abstract
Summary: Background: Forehead and glabella rhytides are treated mostly with neurotoxins, although some practitioners prefer the concurrent use of fillers. It has been suggested that combination treatments can result in a better overall improvement.Aims: To compare the safety and effectiveness of treatment of forehead and glabellar lines with botulinum toxin A alone versus botulinum toxin A and filler.Methods: Split‐face, randomized control trial. Twenty subjects with forehead/glabellar rhytide complex (static and dynamic creases) enrolled. Subjects were randomized and injected with botulinum toxin alone on one side of the forehead/glabella and hyaluronic acid filler followed by botulinum toxin on the other side. Blinded ratings were obtained to assess the effectiveness of treatment for static and dynamic rhytides, respectively, at 2‐week, 6‐week, 3‐month, and 6‐month follow‐up visits. Subjects performed a self‐evaluation at the end of the study. Adverse events were recorded.Results: Ratings of both treatments showed comparable efficacy, with 100% of subjects experiencing improvement from baseline regardless of treatment type at weeks 2, 6, and 12. Combination treatment produced longer‐lasting results in dynamic forehead wrinkles, and greater static and dynamic wrinkle reduction in the glabella at week 24. Subject self‐evaluations showed that both treatments were effective, with a nominal preference for combination treatment.Conclusions: Glabella and forehead lines can be effectively and safely reduced with neurotoxin alone as well as neurotoxin in combination with fillers. Combination treatment may provide a slightly better cumulative benefit and also increase the persistence of effect.Keywords
Funding Information
- Medicis Aesthetics Inc
This publication has 10 references indexed in Scilit:
- Combined treatment with botulinum toxin and hyaluronic acid to correct unsightly lateral-chin depression*Anais Brasileiros de Dermatologia, 2013
- Global, 3‐dimensional approach to natural rejuvenation: part 1 – recommendations for volume restoration and the periocular areaJournal of Cosmetic Dermatology, 2012
- Oculofacial contour asymmetries: Management of combined treatment with hyalurostructure and botulinum toxin injectionsJournal of Cosmetic and Laser Therapy, 2012
- Phosphatidylcholine/deoxycholate lipolysis and hyaluronic acid augmentation to enhance nonsurgical lower facial contouring using botulinum toxin type AJournal of Cosmetic Dermatology, 2011
- Multicenter, Randomized, Parallel-Group Study of OnabotulinumtoxinA and Hyaluronic Acid Dermal Fillers (24-mg/mL Smooth, Cohesive Gel) Alone and in Combination for Lower Facial Rejuvenation: Satisfaction and Patient-Reported OutcomesDermatologic Surgery, 2010
- Multicenter, Randomized, Parallel-Group Study of the Safety and Effectiveness of OnabotulinumtoxinA and Hyaluronic Acid Dermal Fillers (24-mg/mL Smooth, Cohesive Gel) Alone and in Combination for Lower Facial RejuvenationDermatologic Surgery, 2010
- Comparison of Treatment of Melomental Fold Rhytides with Cross-Linked Hyaluronic Acid Combined with OnabotulinumtoxinA and Cross-Linked Hyaluronic Acid AloneDermatologic Surgery, 2010
- Medical rhinoplasty with hyaluronic acid and botulinum toxin A: a very simple and quite effective techniqueJournal of Cosmetic Dermatology, 2008
- A Prospective, Randomized, Parallel Group Study Analyzing the Effect of BTX-A (Botox) and Nonanimal Sourced Hyaluronic Acid (NASHA, Restylane) in Combination Compared with NASHA (Restylane) Alone in Severe Glabellar Rhytides in Adult Female Subjects: Treatment of Severe Glabellar Rhytides with a Hyaluronic Acid Derivative Compared with the Derivative and BTX-ADermatologic Surgery, 2003
- Deep Resting Glabellar Rhytides Respond to BTX-A and Hylan BDermatologic Surgery, 2003